GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » CryoPort Inc (NAS:CYRX) » Definitions » YoY EBITDA Growth

CryoPort (CryoPort) YoY EBITDA Growth : -13,937.50% (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is CryoPort YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. CryoPort's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -13,937.50%.

CryoPort's EBITDA per Share for the three months ended in Dec. 2023 was $-1.12.

CryoPort YoY EBITDA Growth Historical Data

The historical data trend for CryoPort's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CryoPort YoY EBITDA Growth Chart

CryoPort Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -42.30 -21.20 -930.23 97.67 -980.95

CryoPort Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99.85 147.20 -450.00 -311.36 -13,937.50

CryoPort YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

CryoPort's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-1.362--0.126)/ | -0.126 |
=-980.95 %

CryoPort's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-1.123--0.008)/ | -0.008 |
=-13,937.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CryoPort YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of CryoPort's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

CryoPort (CryoPort) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » CryoPort Inc (NAS:CYRX) » Definitions » YoY EBITDA Growth
Comparable Companies
PBI RLGT SFWL CRGO AIRT JANL JYD GVH SGLY PDPTF UPS FDX XTER:DHL XSWX:KNIN OCSE:DSV SZSE:002352 JBHT EXPD HKSE:01519 ZTO
Traded in Other Exchanges
CKX:Germany
Address
112 Westwood Place, Suite 350, Brentwood, TN, USA, 37027
Website
https://www.cryoport.com
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Executives
Robert J Hariri director 341 MENDHAM ROAD, BERNARDSVILLE NJ 07924
Jerrell Shelton director, officer: President, CEO C/O NETRATINGS INC, 120 WEST 45TH STREET 35TH FLOOR, NEW YORK NY 10036
Richard J Berman director 305 COLLEGE ROAD EAST, PRINCETON NJ 08540
Robert Stefanovich officer: Chief Financial Officer
Mark W Sawicki officer: Chief Scientific Officer 3303 LAKEPOINTE DRIVE, BELMONT NC 28012
Blackstone Holdings Ii L.p. 10 percent owner C/O BLACKSTONE INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Tactical Opportunities Fund - Fd L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Daniel M Hancock director 7729 S. BELMONT, INDIANAPOLIS IN 46217
Edward J Zecchini director 20382 BARENTS SEA CIRCLE, LAKE FOREST CA 92630
Linda Baddour director PRA INTERNATIONAL, 12120 SUNSET HILLS ROAD, SUITE 600, RESTON VA 20190
Ramkumar Mandalam director 4344 PICKEREL DRIVE, UNION CITY CA 94587
Ram M. Jagannath director C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Stephen A Schwarzman 10 percent owner C/O BLACKSTONE INC., 345 PARK AVE, NEW YORK NY 10154
Blackstone Tactical Opportunities Associates Iii - Nq L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Freeze Parent L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154